ArticleCancer medicine2024

Comparison of treatment outcome between first-line combination immunotherapy (anti-PD-L1 or anti-PD1) with or without chemotherapy and chemotherapy alone in advanced non-small cell lung cancer patients in tertiary care hospital.

Danainut Naratornsirakul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.